Glenmark Pharmaceuticals Limited (BOM:532296)

Glenmark Pharmaceuticals Statistics

Total Valuation

BOM:532296 has a market cap or net worth of INR 621.18 billion. The enterprise value is 615.35 billion.

Market Cap	621.18B
Enterprise Value	615.35B

Important Dates

The last earnings date was Friday, May 29, 2026.

Earnings Date	May 29, 2026
Ex-Dividend Date	Oct 3, 2025

Share Statistics

Current Share Class	282.20M
Shares Outstanding	n/a
Shares Change (YoY)	+0.03%
Shares Change (QoQ)	-0.05%
Owned by Insiders (%)	3.12%
Owned by Institutions (%)	37.30%
Float	141.59M

Valuation Ratios

The trailing PE ratio is 45.61 and the forward PE ratio is 27.59.

PE Ratio	45.61
Forward PE	27.59
PS Ratio	3.56
PB Ratio	5.91
P/TBV Ratio	7.76
P/FCF Ratio	29.76
P/OCF Ratio	18.03
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.23, with an EV/FCF ratio of 29.48.

EV / Earnings	45.18
EV / Sales	3.53
EV / EBITDA	12.23
EV / EBIT	13.80
EV / FCF	29.48

Financial Position

The company has a current ratio of 1.77, with a Debt / Equity ratio of 0.06.

Current Ratio	1.77
Quick Ratio	0.96
Debt / Equity	0.06
Debt / EBITDA	0.12
Debt / FCF	0.28
Interest Coverage	21.37

Financial Efficiency

Return on equity (ROE) is 14.07% and return on invested capital (ROIC) is 33.92%.

Return on Equity (ROE)	14.07%
Return on Assets (ROA)	15.50%
Return on Invested Capital (ROIC)	33.92%
Return on Capital Employed (ROCE)	32.96%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	11.04M
Profits Per Employee	861,931
Employee Count	15,800
Asset Turnover	0.97
Inventory Turnover	1.47

Taxes

In the past 12 months, BOM:532296 has paid 6.23 billion in taxes.

Income Tax	6.23B
Effective Tax Rate	31.38%

Stock Price Statistics

The stock price has increased by +64.87% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+64.87%
50-Day Moving Average	2,259.15
200-Day Moving Average	2,050.96
Relative Strength Index (RSI)	46.19
Average Volume (20 Days)	26,882

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BOM:532296 had revenue of INR 174.43 billion and earned 13.62 billion in profits. Earnings per share was 48.24.

Revenue	174.43B
Gross Profit	126.96B
Operating Income	44.60B
Pretax Income	19.85B
Net Income	13.62B
EBITDA	50.33B
EBIT	44.60B
Earnings Per Share (EPS)	48.24

Balance Sheet

The company has 11.76 billion in cash and 5.94 billion in debt, with a net cash position of 5.83 billion.

Cash & Cash Equivalents	11.76B
Total Debt	5.94B
Net Cash	5.83B
Net Cash Per Share	n/a
Equity (Book Value)	105.12B
Book Value Per Share	372.48
Working Capital	49.23B

Cash Flow

In the last 12 months, operating cash flow was 34.45 billion and capital expenditures -13.58 billion, giving a free cash flow of 20.87 billion.

Operating Cash Flow	34.45B
Capital Expenditures	-13.58B
Depreciation & Amortization	5.73B
Net Borrowing	-23.57B
Free Cash Flow	20.87B
FCF Per Share	n/a

Margins

Gross margin is 72.78%, with operating and profit margins of 25.57% and 7.81%.

Gross Margin	72.78%
Operating Margin	25.57%
Pretax Margin	11.38%
Profit Margin	7.81%
EBITDA Margin	28.85%
EBIT Margin	25.57%
FCF Margin	11.97%

Dividends & Yields

This stock pays an annual dividend of 5.00, which amounts to a dividend yield of 0.22%.

Dividend Per Share	5.00
Dividend Yield	0.22%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	10.36%
Buyback Yield	-0.03%
Shareholder Yield	0.18%
Earnings Yield	2.19%
FCF Yield	3.36%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on September 10, 2007. It was a forward split with a ratio of 2.

Last Split Date	Sep 10, 2007
Split Type	Forward
Split Ratio	2

Scores

Altman Z-Score	n/a
Piotroski F-Score	7